Evidence map›Paper›PMID 41186794›Full record

GuidelineInternational journal of clinical oncology2025

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer.

Yusuke Kinugasa, Kay Uehara, Kensei Yamaguchi, Yutaka Saito, Keiko Murofushi, Tamotsu Sugai, Megumi Ishiguro, Soichiro Ishihara, Hideki Ueno, Shiro Oka and 22 more

Abstract readPractice Guideline
In one paragraph

Guideline in International journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Association between cancer cachexia and treatment-related adverse outcomes in patients with gastrointestinal cancers: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Yusuke KinugasaDepartment of Gastrointestinal Surgery, Institute of Science Tokyo (Science Tokyo) Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. kinugasa.srg1@tmd.ac.jp.ORCID http://orcid.org/0000-0002-7885-2276
Kay UeharaDepartment of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9669-5860
Kensei YamaguchiDepartment of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6887-5709
Yutaka SaitoEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2296-8373
Keiko MurofushiDivision of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Tamotsu SugaiPathology, Southern Tohoku Research Institute for Neuroscience Southern Tohoku General Hospital, Fukushima, Japan.ORCID http://orcid.org/0000-0002-4896-3557
Megumi IshiguroHealth Science Research and Development Center, Institute of Science Tokyo Hospital, Tokyo, Japan.
Soichiro IshiharaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0543-0045
Hideki UenoDepartment of Surgery, National Defense Medical College, Saitama, Japan.ORCID http://orcid.org/0000-0002-8600-1199
Shiro OkaDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-1652-0743
Takeshi KatoDepartment of Surgery, NHO Osaka National Hospital, Osaka, Japan.
Yukihide KanemitsuDepartment of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3366-3826
Hisato KawakamiDepartment of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.ORCID http://orcid.org/0000-0002-3280-4850
Hirotoshi KobayashiDepartment of Surgery, Mizonokuchi Hospital, Teikyo University School of Medicine, Kanagawa, Japan.ORCID http://orcid.org/0000-0001-6331-6887
Yoshihiro SakamotoDepartment of Gastroenterological and General Surgery, Kyorin University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7279-9702
Manabu ShiozawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan.ORCID http://orcid.org/0009-0006-1912-5948
Akio ShiomiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.ORCID http://orcid.org/0000-0001-5657-8686
Eiji ShinozakiDepartment of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID http://orcid.org/0000-0002-7448-5894
Hirotoshi TakiyamaQST Hospital, National Institutes for Quantum Science and Technology, Chiba, Japan.
Hiroya TaniguchiDepartment of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.ORCID http://orcid.org/0000-0003-1407-6682
Takako Eguchi NakajimaDepartment of Early Clinical Development, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kinichi HottaDivision of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.ORCID http://orcid.org/0000-0001-5608-0968
Keiji MatsudaDepartment of Surgery, Fraternity Memorial Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-1507-1077
Kohei MurataDepartment of Surgery, Osaka Rosai Hospital, Osaka, Japan.
Satoshi MoritaDepartment of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kentaro YamazakiDivision of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Masahiro YoshidaDepartment of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, School of Medicine, International University of Health and Welfare, Chiba, Japan.
Naohiko YamaguchiLibrary of SEIREI, SAKURA Citizen Hospital, Sakura, Japan.
Hiroyasu KagawaDepartment of Gastrointestinal Surgery, Institute of Science Tokyo (Science Tokyo) Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.ORCID http://orcid.org/0000-0001-8741-8992
Shinichi YamauchiDepartment of Gastrointestinal Surgery, Institute of Science Tokyo (Science Tokyo) Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.ORCID http://orcid.org/0000-0002-2360-5323
Yoichi AjiokaDivision of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Japanese Society for Cancer of the Colon and Rectum

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of deaths from colorectal cancer in Japan continues to rise, with over 50,000 deaths recorded in 2018. In the 2024 edition, revisions to all aspects of treatment were undertaken, with corrections and additions made based on knowledge gained since the 2022 version (drug therapy) and the 2019 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer have been prepared to present standard treatment strategies, reduce disparities among institutions, avoid both unnecessary and insufficient treatment, and enhance mutual understanding between healthcare professionals and patients by making these guidelines accessible to the public. These guidelines were developed through consensus by the JSCCR Guideline Committee, following a careful review of evidence retrieved from literature searches and considering the medical insurance system and actual clinical practice in Japan. Therefore, these guidelines serve as a tool for managing colorectal cancer in real-world clinical settings. More specifically, they can be used to support obtaining informed consent from patients and selecting the most appropriate treatment method for each patient. Controversial topics were selected as clinical questions, and recommendations were provided. Each recommendation is accompanied by an evidence classification and a recommendation category, both based on consensus reached by the Guideline Committee members. This article presents the English version of the JSCCR guidelines 2024.

Indexed as

Colorectal NeoplasmsHumansJapanSocieties, MedicalChemotherapyColorectal cancerEndoscopyGuidelineRadiotherapySurgery

Identifiers

PMID41186794
PMCPMC12644182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.